FDA approves additional medical indication for Sprycel
Links shared publicly online about this topic.
- 768total visits
FDA approves additional medical indication for Sprycel
View full resource at drugs.com
Tags: Leukemia, Chronic Myelogenous Leukemia, Drug, FDA
Most Recently Shared on October 28, 2010 at 11:24 pm By:
FDA approves additional medical indication for Sprycel: SILVER SPRING, Md., Oct. 28 - The U.S. Food and Drug ... http://bit.ly/cA1b5e #drug
Therapeutics Daily
therapeuticsdaily.com — “Therapeutics Daily” View full resource at therapeuticsdaily.com
Most Recently Shared on November 1, 2010 at 6:13 pm By:
Therapeutics Daily - FDA Approves Additional Medical Indication for Sprycel - http://tinyurl.com/279xfw4
FDA Approves Additional Medical Indication for Sprycel - Drugs.com MedNews
drugs.com — “Patients with rare type of leukemia now have another treatment option The U.S. Food and Drug Administration today approved a new indication for Sprycel (dasatin” View full resource at drugs.com
Most Recently Shared on October 29, 2010 at 1:16 pm By:
FDA Approves Additional Medical Indication for Sprycel: Patients with rare type of leukemia now have another ... http://bit.ly/c4kBZd #drug
FDA approves additional medical indication for Sprycel
drugs.com — “Sprycel (dasatinib) is now approved to treat newly diagnosed adults with Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML) in chronic phase. Includes Sprycel side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on October 28, 2010 at 10:35 pm By:
FDA approves additional medical indication for Sprycel - http://bit.ly/cudetK
Medical News: Dasatinib Wins First-Line Indication in CML - in Oncology/Hematology, Leukemia from MedPage Today
medpagetoday.com — “WASHINGTON -- The FDA approved an additional indication for dasatinib (Sprycel) as a first-line therapy for patients with Philadelphia chromosome positive chronic phase chronic myeloid leukemia (Ph+ C” View full resource at medpagetoday.com
Most Recently Shared on October 28, 2010 at 9:29 pm By:
Dasatinib Wins First-Line Indication in CML http://ow.ly/19GFT4
Medical News: FDA Okays New Indication for COPD Inhaler - in Pulmonology, COPD from MedPage Today
medpagetoday.com — “WASHINGTON -- The FDA has expanded the approved indications for inhaled tiotropium bromide (Spiriva) to include reducing exacerbations of chronic obstructive pulmonary disease (COPD), in addition to i” View full resource at medpagetoday.com
Most Recently Shared on December 18, 2009 at 7:09 pm By:
FDA Okays New Indication for COPD Inhaler WASHINGTON (MedPage Today) -- The FDA has expanded the approved indications.. http://bit.ly/60RxSR
Advertisement

